HCA Healthcare price target raised to $431 from $412 at Wells Fargo

Wells Fargo raised the firm’s price target on HCA Healthcare (HCA) to $431 from $412 and keeps an Equal Weight rating on the shares following quarterly results. Overall, modestly higher EBITDA estimates and rolling fully to 2027 estimates offsets a material increase in the odds of enhanced exchange subsidies expiring in the firm’s price target framework, Wells says.